Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Bellicum Pharma Comm
(NQ:
BLCM
)
4.470
USD
-0.390 (-8.02%)
Official Closing Price
Updated: 7:58 PM EST, Feb 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Bellicum Pharma Comm
< Previous
1
2
3
4
5
6
7
Next >
Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin
February 08, 2021
Rapha Capital Management Leads Convertible Note Financing
From
PR Newswire
Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
January 28, 2021
From
GlobeNewswire News Releases
Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603
December 10, 2020
From
GlobeNewswire News Releases
Bellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial
December 07, 2020
From
GlobeNewswire News Releases
Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update
November 05, 2020
From
GlobeNewswire News Releases
Bellicum Pharmaceuticals Announces Closing of $25.0 Million Underwritten Offering
November 03, 2020
From
GlobeNewswire News Releases
Bellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market
October 29, 2020
From
GlobeNewswire News Releases
Bellicum Announces Interim BPX-601 Data and Corporate Restructuring
October 29, 2020
From
GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2020
From
GlobeNewswire News Releases
Bellicum to Participate in Two Upcoming Virtual Conferences
September 28, 2020
From
GlobeNewswire News Releases
Bellicum to Participate in Two Upcoming Virtual Investor Conferences
September 02, 2020
From
GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 31, 2020
From
GlobeNewswire News Releases
Bellicum Reports Second Quarter 2020 Financial Results and Provides Operational Update
August 06, 2020
From
GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 31, 2020
From
GlobeNewswire News Releases
Bellicum to Report Second Quarter 2020 Financial Results and Provide Corporate Update
July 30, 2020
Management to host webcast and conference call on Thursday, August 6, 2020 at 5 p.m. ET / 2 p.m. PT
From
GlobeNewswire News Releases
Bellicum Receives FDA IND Clearance to Initiate a Phase 1/2 Clinical Trial for BPX-603, a Dual-Switch GoCAR-T® for HER2+ Solid Tumors
June 15, 2020
From
GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 29, 2020
From
GlobeNewswire News Releases
Bellicum Announces Publication of Data for GoCAR-NK™ Cell Program
May 27, 2020
From
GlobeNewswire News Releases
Bellicum to Participate in Two Upcoming Virtual Investor Conferences
May 27, 2020
From
GlobeNewswire News Releases
Bellicum Reports First Quarter 2020 Financial Results and Provides Operational Update
May 07, 2020
From
GlobeNewswire News Releases
Rapha Capital Management Leads Series A Financing for FIZE Medical Inc.
May 04, 2020
FIZE's Novel Device Conquers the Last Frontier in Patient Monitoring
From
PR Newswire
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 30, 2020
From
GlobeNewswire News Releases
Bellicum Completes Sale of Houston Facility
April 15, 2020
From
GlobeNewswire News Releases
Bellicum Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Operational Update
March 12, 2020
From
GlobeNewswire News Releases
Bellicum to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update
March 05, 2020
Management to host webcast and conference call on Thursday, March 12, 2020 at 5 p.m. ET / 2 p.m. PT
From
GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 28, 2020
From
GlobeNewswire News Releases
Bellicum Announces Reverse Stock Split
February 05, 2020
From
GlobeNewswire News Releases
Bellicum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 31, 2020
From
GlobeNewswire News Releases
Bellicum Presents New Translational Data for BPX-601 at ASCO GI Cancers Symposium
January 24, 2020
From
GlobeNewswire News Releases
Bellicum Pharmaceuticals Enters into Asset Purchase and Master Services Agreements with MD Anderson
January 21, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.